{"id":559577,"title":"Australia Canada Singapore Switzerland (ACSS) Consortium – Erleada approval - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-15","captureTimestamp":"2026-02-15T01:43:31.311000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/notice-erleada.html","snippet":"Australia Canada Singapore Switzerland (ACSS) Consortium – Erleada approval July 13, 2018 Our file number: 18-108470-709 On July 4, 2018 Health Canada approved the first drug to be evaluated under the Australia-Canada-Singapore-Switzerland (ACSS) Consortium’s New Chemical…","rawSnapshotUrl":"/api/snapshots/raw/559577","browseUrl":"https://replay.healtharchive.ca/job-6/20260215014331/https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/notice-erleada.html#ha_snapshot=559577","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}